The residues of furazolidone and its metabolites (3-amino-2-oxazolidinone [AOZ]) in food would have adverse effects on humans. Herein, a colorimetric and fluorescent dual-signal output immunochromatographic method with a zirconium-based porphyrin metal-organic framework (PCN-222) as the signal label was developed for the detection of 3-[(4-carboxyphenyl) monomethyl] amino-2-oxazolidinone (CPAOZ), a derivative of furazolidone metabolite. PCN-222 was synthesized using the solvothermal method, and the material was characterized via scanning electron microscopy, Fourier-transform-infrared spectroscopy, and powder X-ray diffraction, which proved the successful synthesis of PCN-222. Synthesized PCN-222, as a nanotag, was bound to antibodies to prepare PCN-222-mAbs with dual optical properties. Under the optimized conditions, PCN-222- lateral flow assay (LFA) exhibited a great linear relationship in the range of 0.25–100 ng/mL. The visual limit detection of CPAOZ using colorimetric and fluorescent signals were 1.0 ng/mL and 0.5 ng/mL, respectively, and the sensitivity was 5- and 10-fold higher than that of the colloidal gold-based LFA method. In addition, PCN-222-LFA was successfully applied to the detection of CPAOZ in shrimp, chicken and milk samples achieving satisfactory recoveries from 92.34% to 117.44%. This study provides an alternative, convenient and sensitive method for the rapid detection of veterinary drug residues.
No takes yet. Share an insight, caveat, or question.
Zhong et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: